期刊文献+

导管射频消融术治疗阵发性心房颤动合并快慢综合征的临床效果 被引量:4

Clinical effect of radiofrequency catheter ablation in the treatment of paroxysmal atrial fibrillation with tachycardia-bradycardia syndrome
暂未订购
导出
摘要 目的分析导管射频消融术治疗阵发性心房颤动合并快慢综合征的临床效果。方法选择2015年3月至2020年3月我院收治的58例阵发性心房颤动合并快慢综合征患者作为研究对象,采用随机数字表法将其分为参照组和导管射频消融组,各29例。参照组接受常规抗心律失常药物治疗,导管射频消融组在参照组基础上接受导管射频消融术治疗。比较两组的治疗效果。结果治疗3个月后,两组左室舒张末期内径(LVEDD)小于治疗前,平均心率(MEHR)、左室射血分数(LVEF)高于治疗前,且导管射频消融组优于参照组(P<0.05)。治疗3个月后,两组最长RR间期(MRRI)短于治疗前,左房中侧径小于治疗前,且导管射频消融组优于参照组(P<0.05)。治疗3个月后,导管射频消融组症状控制优良率为93.10%,明显高于参照组的68.97%(P<0.05)。治疗12个月后,导管射频消融组房颤复发率为3.45%,明显低于参照组的34.48%(P<0.05)。结论导管射频消融术治疗阵发性心房颤动合并快慢综合征患者效果显著,可明显改善患者的心功能指标,控制症状,降低房颤复发率,部分患者可避免起搏器植入。 Objective To analyze the clinical effect of radiofrequency catheter ablation in the treatment of paroxysmal atrial fibrillation with tachycardia-bradycardia syndrome.Methods From March 2015 to March 2020,58 patients with paroxysmal atrial fibrillation and tachycardia-bradycardia syndrome admitted in our hospital were selected as the research objects,and the patients were divided into reference group and radiofrequency catheter ablation group by random number table method,with 29 cases in each group.The reference group received conventional antiarrhythmic drugs,and the radiofrequency catheter ablation group received radiofrequency catheter ablation on the basis of the reference group.The therapeutic effects of the two groups were compared.Results After 3 months of treatment,the left ventricular end diastolic diameter(LVEDD)in the two groups were smaller than those before treatment,the mean heart rate(MEHR)and left ventricular ejection fraction(LVEF)were higher than those before treatment,and those in the radiofrequency catheter ablation group were better than the reference group(P<0.05).After 3 months of treatment,the maximum RR interval(MRRI)in the two groups were shorter than those before treatment,the left atrium medial diameter were smaller than those before treatment,and those in the radiofrequency catheter ablation group were better than the reference group(P<0.05).After 3 months of treatment,the excellent and good rate of symptom control in the radiofrequency catheter ablation group was 93.10%,which was significantly higher than 68.97% in the reference group(P<0.05).After 12 months of treatment,the recurrence rate of atrial fibrillation in the radiofrequency catheter ablation group was 3.45%,which was significantly lower than 34.48%in the reference group(P<0.05).Conclusion Radiofrequency catheter ablation in the treatment of paroxysmal atrial fibrillation with tachycardia-bradycardia syndrome has a significant effect,which can significantly improve the cardiac function indexes of patients,control symptoms,reduce the recurrence rate of atrial fibrillation,and some patients can avoid pacemaker implantation.
作者 薛仙军 许岭平 XUE Xianjun;XU Lingping(No.2 Ward of Internal Medicine-Cardiovascular Department,Xianyang Central Hospital,Xianyang 712000,China)
出处 《临床医学研究与实践》 2021年第12期30-32,共3页 Clinical Research and Practice
基金 院内科研创新项目(咸中心医字〔2017〕25号)。
关键词 导管射频消融术 阵发性心房颤动 快慢综合征 心功能指标 catheter radiofrequency ablation paroxysmal atrial fibrillation tachycardia-bradycardia syndrome cardiac function indexes
  • 相关文献

参考文献10

二级参考文献62

  • 1吴书林,薛玉梅,黄俊.心房颤动导管消融围术期抗凝治疗进展[J].中国医学前沿杂志(电子版),2012,4(12):8-12. 被引量:4
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1408
  • 3刘少稳,杨延宗,高连君,李世军,尹晓盟,林治湖.心房颤动导管射频消融静脉电隔离前后的抗凝治疗[J].中国心脏起搏与心电生理杂志,2004,18(6):432-434. 被引量:11
  • 4董建增,马长生,刘兴鹏,龙德勇,刘小青,王京,刘闯,李勇胜,藏敏华,刘晓慧.环肺静脉线性消融电学隔离肺静脉治疗100例心房颤动临床评价[J].中华心血管病杂志,2005,33(10):907-911. 被引量:39
  • 5吴钢,江洪,黄从新,杨波,万军,唐艳红,雷汉东,王晓红,刘华芬,彭彬.环肺静脉射频消融术治疗心房颤动复发的预测因子探讨[J].中华心律失常学杂志,2007,11(4):306-307. 被引量:15
  • 6Jun HJ, Kim K J, Chun IA, et al. The relationship between stroke patients' socio-economic conditions and their quality of life: the 2010 Korean community health survey [ J ]. J Phys Ther Sci, 2015, 27(3) :781-784.
  • 7Ltideritz B, Jung W. Quality of life in atrial fibrillation [ J ]. J Interv Card Electrophysiol, 2000,4 Suppl 1:201-209.
  • 8January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coil Cardiol, 2014, 64(21 ) :el-76.
  • 9Carnl~f C, Insulander P, Pettersson PH, et al. Health-related quality of life in patients with atrial fibrillation undergoing pulmonary vein isolation, before and after treatment [J].Eur J Cardiovasc Nurs, 2010,9( 1 ) :45-49.
  • 10Reynolds MR, Gunnarsson CL, Hunter TD, et al. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis [ J ]. Cire Cardiovasc Qual Outcomes, 2012, 5 ( 2 ) : 171-181.

共引文献86

同被引文献49

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部